Skip to Main Content

Paper Details

Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial.
BMJ Open
9
2021
Author NameAffiliation
S??bastien Gibot
Pierre-Fran??ois LaterreCliniques Universitaires Saint-Luc
  • 1 - 2

Datasets

Release 1.2